Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
ASXL1 gene is often mutated in myeloid malignancies. Here, the authors show that mutant ASXL1 and BAP1 are in a positive feedback loop such that BAP1 induces monoubiquitination of mutant ASXL1, which in turn enhances BAP1 activity to potentiate myeloid transformation via HOXA clusters and IRF8.
Guardado en:
Autores principales: | Shuhei Asada, Susumu Goyama, Daichi Inoue, Shiori Shikata, Reina Takeda, Tsuyoshi Fukushima, Taishi Yonezawa, Takeshi Fujino, Yasutaka Hayashi, Kimihito Cojin Kawabata, Tomofusa Fukuyama, Yosuke Tanaka, Akihiko Yokoyama, Satoshi Yamazaki, Hiroko Kozuka-Hata, Masaaki Oyama, Shinya Kojima, Masahito Kawazu, Hiroyuki Mano, Toshio Kitamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b54c40c22a2a4a1b8cfc19f69a4b3607 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
por: Takeshi Fujino, et al.
Publicado: (2021) -
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Salima Daou, et al.
Publicado: (2018) -
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Danny D. Sahtoe, et al.
Publicado: (2016) -
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
por: Madison J. Kelly, et al.
Publicado: (2019) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Jean-Baptiste Micol, et al.
Publicado: (2017)